Immunoadsorption versus plasma exchange versus combination for treatment of myasthenic deterioration.
Saved in:
| Title: | Immunoadsorption versus plasma exchange versus combination for treatment of myasthenic deterioration. |
|---|---|
| Authors: | Schneider-Gold C; Department of Neurology, University of Würzburg, Würzburg, Germany., Krenzer M; Department of Neurology, University of Würzburg, Würzburg, Germany., Klinker E; Transfusion Medicine, University of Würzburg, Würzburg, Germany., Mansouri-Thalegani B; Transfusion Medicine, University of Würzburg, Würzburg, Germany., Müllges W; Department of Neurology, University of Würzburg, Würzburg, Germany., Toyka KV; Department of Neurology, University of Würzburg, Würzburg, Germany., Gold R; Department of Neurology, St. Josef-Hospital, Ruhr-Universität Bochum, Gudrunstr. 56, 44791 Bochum, Germany. |
| Source: | Therapeutic advances in neurological disorders [Ther Adv Neurol Disord] 2016 Jul; Vol. 9 (4), pp. 297-303. Date of Electronic Publication: 2016 Mar 10. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: SAGE Country of Publication: England NLM ID: 101480242 Publication Model: Print-Electronic Cited Medium: Print ISSN: 1756-2856 (Print) Linking ISSN: 17562856 NLM ISO Abbreviation: Ther Adv Neurol Disord Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1756-2856 |
|---|---|
| DOI: | 10.1177/1756285616637046 |
